Download
Mobile
Desktop
Download now
View more versions
About us
English
中文繁體
中文简体
Markets
Stocks
Real-time stock quotes
Options
In-depth options trading
Futures
Invest in futures contracts
ETF
Diversify with exchange-traded funds
Forex
Trade global currencies
Products
Screener
Top performing stocks
Heat Map
Spot emerging industry trends
Institutional Tracker
Institutional investment strategies
Sparks
Disruptive investment opportunities
Earnings Calendar
Follow upcoming earnings reports
News
Headlines
The most important news of the day
24/7
Get current, latest, and breaking news 24/7
Financial Calendar
Find earnings, economics, and IPO calendars
Topics
Explore trending topics in investing and business
Video
Watch the market news & analysis
Moo Community
Feed
Find inspiration for your next move
Topics
Discuss hot topics with like-minded traders
Featured Content
Talk the latest earnings reports and trades
Learn
Courses
Everything you need to learn about investing
Options
Stocks
Strategies and Insights
Perspectives
Funds
Moomoo Tutorials
Earnings Report Forecast
Library
Your complete guide to investing basics
Learn Premium
Expand and apply your investment skills and knowledge
Investing
Investment Choices
Explore investment products
Cash Sweep
Stocks
Fractional Shares
ETFs
Options
Margin Trade
Features
See our powerful trading features in action
Charts
Stock Analysis
Level 2 Data
Nasdaq Market Depth
Pricing
Transparent fees, no account minimums
Investing products, features and pricing are provided by Moomoo Financial Inc
Log in
Open Account
Financial services in the moomoo app are provided by Moomoo Financial Inc. You will be redirected to Moomoo Financial Inc's web domain, where the account application pages are hosted.
Sign up/Log in
Account Info
Log Out
English
Back
Markets
Stocks
Real-time stock quotes
Options
In-depth options trading
Futures
Invest in futures contracts
ETF
Diversify with exchange-traded funds
Forex
Trade global currencies
Products
Heat Map
Spot emerging industry trends
Institutional Tracker
Institutional investment strategies
Sparks
Disruptive investment opportunities
Earnings Calendar
Follow upcoming earnings reports
News
Headlines
The most important news of the day
24/7
Get current, latest, and breaking news 24/7
Financial Calendar
Find earnings, economics, and IPO calendars
Topics
Explore trending topics in investing and business
Video
Watch the market news & analysis
Moo Community
Feed
Find inspiration for your next move
Featured Content
Talk the latest earnings reports and trades
Learn
Courses
Options
Stocks
Strategies and Insights
Perspectives
Funds
Moomoo Tutorials
Earnings Report Forecast
Library
Your complete guide to investing basics
Learn Premium
Expand and apply your investment skills and knowledge
Investing
Investment Choices
Cash Sweep
Stocks
Fractional Shares
ETFs
Options
Margin Trade
Features
Charts
Stock Analysis
Level 2 Data
Nasdaq Market Depth
Pricing
Transparent fees, no account minimums
Investing products, features and pricing are provided by Moomoo Financial Inc
English
中文繁體
中文简体
Dark
Light
Download
Log in to access Online Inquiry
Back to the Top
Verified Account
HANYong zhe
shared · Nov 5, 2021 08:40
[Share Link: Pfizer: In phase 2/3 studies, the effectiveness...
Pfizer: In phase 2/3 studies, the effectiveness of the antiviral drug against COVID-19 is 89%.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
See Original
Report
184 Views
Comment
Sign in
to post a comment
HANYong zhe
5
Followers
74
Following
18
Visitors
Follow
